Patients with radiation retinopathy who were destined to go blind within five years now can keep their sight longer through localized treatment with Avastin, a well-known cancer drug, according to a two-year study published in the June, 2007 Archives of Ophthalmology. “This is a major breakthrough for eye cancer patients who are treated with radiation therapy and commonly develop radiation retinopathy,” said Paul T. [click link for full article]